🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementGallbladder disease risk — looking for input Page 3

Gallbladder disease risk — looking for input

PharmHunterJen Sun, Mar 17, 2024 at 12:32 PM 15 replies 2,145 viewsPage 3 of 3
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Mar 17, 2024 at 4:47 PM#11
TrialTracker_MD said:
Gallbladder disease risk looking is not that straightforward in my experience

This is exactly right. TrialTracker_MD articulated what I have been trying to explain to my doctor for months. The Gallbladder disease risk aspect is the most important factor.

Last edited: Mar 17, 2024 at 10:47 PM
45 5Dr.LipidDallas, alex_tucson, kevin_tulsa and 42 others
Reply Quote Save Share Report
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Mar 17, 2024 at 5:04 PM#12

Reading this thread on Gallbladder disease risk hits close to home. Night shift nurse — I started at 279 lbs and felt like I would tried everything.

15 months on tirz and I am a different person. Not just the 54 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Gallbladder disease — take the leap. It was the best health decision I have ever made. ❤️

Last edited: Mar 17, 2024 at 11:04 PM
4 10mark_tokyo, hans_munich, jason_sac26 and 1 other
Reply Quote Save Share Report
marcus_mpls
Member
234
1,123
Nov 2024
Minneapolis, MN
Mar 17, 2024 at 5:21 PM#13

Dr.EndoEP — that is really helpful context on Gallbladder disease risk . Follow-up question: what labs did your doctor order to monitor this?

I am in a similar situation (just started) and trying to set realistic expectations.

Last edited: Mar 17, 2024 at 10:21 PM
36 17tane_welly, Dr.PathRoch, mona_PHX and 33 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
PedsEndoPhilly
Member
345
1,890
Jun 2024
Philadelphia, PA
Mar 17, 2024 at 5:38 PM#14

To answer julia.endo's question specifically:

From a clinical standpoint, Gallbladder disease risk is an area where we have good evidence.

The short answer: baseline labs + quarterly monitoring is the standard of care.

The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.

Last edited: Mar 17, 2024 at 10:38 PM
12 22Dr.LeslieOBGYN, MikeNYC_runner and 9 others
Reply Quote Save Share Report
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Mar 17, 2024 at 5:55 PM#15

Bookmarked 📌 The Gallbladder disease info in this thread is essential. Coming back to this for sure.

5 19emily_PDX, Dr.SleepRoch, laura_annarbor and 2 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register